A personalized vaccine for melanoma cut the risk of cancer returning after five years
An experimental vaccine from Moderna and Merck shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results.
المصدر: NBC News — News
0
مشاهدة
